Exact Sciences · 2 hours ago
AI Engineer Intern – GenAI (Summer 2026)
Madison, WI
Internship
Onsite
Intern
$35K/yr - $56K/yr
Start in 2026 SummerExact Sciences is helping change how the world prevents, detects, and guides treatment for cancer. The AI Engineer Intern – GenAI will support projects involving large language models and generative AI applications, focusing on development and evaluation of AI models and prototyping LLM-powered applications.
BiotechnologyHealth DiagnosticsManufacturingMedical
No H1B
Responsibilities
Develop and evaluate generative AI models for text, code, and other modalities
Explore prompt engineering, fine-tuning, and RAG-based systems
Support prototyping of LLM-powered applications and pipelines
Apply excellent problem-solving skills to improve AI solutions
Display strong communication and teamwork in research and development projects
Uphold company mission and values through accountability, innovation, integrity, quality, and teamwork
Support and comply with the company’s Quality Management System policies and procedures
Maintain regular and reliable attendance
Ability to act with an inclusion mindset and model these behaviors for the organization
Qualification
Required
Master's or PhD candidate in Computer Science, AI, Machine Learning, or related field
Strong proficiency in Python and machine learning frameworks (Scikit-learn, PyTorch, TensorFlow)
Familiarity with large language models (e.g., GPT, LLaMA, Claude) and open-source toolkits (Hugging Face, LangChain)
Authorization to work in the United States without sponsorship
Preferred
Experience with retrieval-augmented generation (RAG) systems
Knowledge of cloud platforms (AWS, Azure, GCP)
Benefits
Paid time off (including days for vacation, holidays, volunteering, and personal time)
Paid leave for parents and caregivers
A retirement savings plan
Wellness support
Health benefits including medical, prescription drug, dental, and vision coverage
Company
Exact Sciences
Exact Sciences offers a portfolio of cancer screening and diagnostic tests that span from early detection to treatment monitoring.
Founded in 1995
5001-10000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.75B2025-06-20Acquired
2024-04-11Post Ipo Debt· $620.7M
2023-02-23Post Ipo Debt· $500M
Leadership Team
Kevin Conroy
Chairman & CEO
Aaron Bloomer
Executive Vice President, CFO
Recent News
2026-01-20
2026-01-20
Company data provided by crunchbase